Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma: Current State and Recent Advances

被引：2
作者：
Yakob M. [1 ]
Fuentes L. [1 ]
Wang M.B. [2 ]
Abemayor E. [2 ]
Wong D.T.W. [1 ]
机构：
[1] Center for Oral/Head & Neck Oncology Research, School of Dentistry, University of California, Los Angeles, 73-017 CHS, 10833 Le Conte Avenue, Los Angeles, 90095, CA
[2] Department of Head and Neck Surgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA
来源：
Current Oral Health Reports | 2014年 / 1卷 / 2期
基金：
美国国家卫生研究院;
关键词：
Exosomes; Metabolomics; Methylomics; Microbiomics; Oral cancer; Oral fluid diagnostics; Oral squamous cell carcinoma; Proteomics; Salivaomics; Salivary biomarker; Salivary diagnostics; Transcriptomics;
D O I：
10.1007/s40496-014-0014-y
中图分类号：
学科分类号：
摘要：
Oral squamous cell carcinoma (OSCC) is the most common malignant neoplasm of the oral cavity. Detection of OSCC is currently based on a thorough clinical oral examination combined with a biopsy for histological analysis. Most cases of OSCC are not detected until the cancer has developed into advanced stages; thus, a reliable early-stage diagnostic marker is needed. This literature review presents an overview of the status of current advances in salivary diagnostics for OSCC. Though many protein and mRNA salivary biomarkers have been identified that can detect OSCC with high sensitivity and specificity, the most discernable findings occur with the use of multiple markers. Studies that incorporate proteomic, transcriptomic, and potentially additional “omics”, including methylomics, need to be initiated to bring technology to clinical applications and allow the best use of saliva in diagnosing OSCC. © 2014, Springer International Publishing AG.
引用
收藏
页码：133 / 141
页数：8
相关论文
共 97 条
[81]  
Viet C.T., Schmidt B.L., Methylation array analysis of preoperative and postoperative saliva DNA in crab cancer patients, Cancer Epidemiol Biomarkers Prev, 17, 12, pp. 3603-3611, (2008)
[82]  
Jithesh P.V., Risk J.M., Schache A.G., Dhanda J., Lane B., Liloglou T., Et al., The epigenetic landscape of oral squamous cell carcinoma, Br J Cancer, 108, 2, pp. 370-379, (2013)
[83]  
Guerrero-Preston R., Soudry E., Acero J., Orera M., Moreno-Lopez L., Macia-Colon G., Et al., NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva, Cancer Prev Res, 4, 7, pp. 1061-1072, (2011)
[84]  
Xia J., Broadhurst D.I., Wilson M., Wishart D.S., Translational biomarker discovery in clinical metabolomics: an introductory tutorial, Metabolomics, 9, 2, pp. 280-299, (2013)
[85]  
Patti G.J., Yanes O., Siuzdak G., Innovation: metabolomics: the apogee of the omics trilogy, Nat Rev Mol Cell Biol, 13, 4, pp. 263-269, (2012)
[86]  
Tripathi P., Kamarajan P., Somashekar B.S., MacKinnon N., Chinnaiyan A.M., Kapila Y.L., Et al., Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target, Int J Biochem Cell Biol, 44, 11, pp. 1852-1861, (2012)
[87]  
Lee Y., El Andaloussi S., Wood M.J., Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy, Hum Mol Genet, 21, R1, pp. R125-R134, (2012)
[88]  
Ogawa Y., Miura Y., Harazono A., Kanai-Azuma M., Akimoto Y., Kawakami H., Et al., Proteomic analysis of two types of exosomes in human whole saliva, Biol Pharm Bull, 34, 1, pp. 13-23, (2011)
[89]  
Ogawa Y., Kanai-Azuma M., Akimoto Y., Kawakami H., Yanoshita R., Exosome-like vesicles with dipeptidyl peptidase IV in human saliva, Biol Pharm Bull, 31, 6, pp. 1059-1062, (2008)
[90]  
Kim J.W., Wieckowski E., Taylor D.D., Reichert T.E., Watkins S., Whiteside T.L., Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes, Clin Cancer Res, 11, 3, pp. 1010-1020, (2005)
12345678910